Stay updated on Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial

Sign up to get notified when there's something new on the Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page’s footer/site revision has been updated from v3.5.2 to v3.5.3, indicating a ClinicalTrials.gov interface/platform version update rather than a change to the study record itself.
    Difference
    0.1%
    Check dated 2026-04-24T16:41:15.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision history shows Revision: v3.5.2 added and Revision: v3.5.0 removed.
    Difference
    0.1%
    Check dated 2026-04-17T13:26:07.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added to the history and Revision: v3.4.3 was removed. This reflects an update to the revision log rather than changes to study data or user-facing content.
    Difference
    0.1%
    Check dated 2026-03-19T09:59:48.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added to the history, and Revision: v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-12T04:59:42.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and older notices (Revision: v3.4.1 and a government funding status notice) were removed, indicating a UI/version update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T15:45:39.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    A new revision v3.4.1 was added and v3.4.0 removed, and a site-wide notice regarding government funding and NIH operations was introduced. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:52:48.000Z thumbnail image

Stay in the know with updates to Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial page.